Barbara Tantillo Rn Bsn

Head Audits And Compliance at Daiichi Sankyo

Barbara Tantillo RN BSN MS has a diverse work experience in the pharmaceutical industry. From 2001 to 2023, they held various roles in different companies, contributing to quality assurance, compliance, auditing, and medical affairs. Their roles included Head Audits and Compliance at Daiichi Sankyo, Inc., where they started in 2013 and is currently still employed. Barbara also worked as an Associate Director at Grunenthal USA Inc from 2010 to 2013. Earlier in their career, they held positions such as Assistant Director GCP Compliance/Compliance Specialist at Mederex/Bristol Myers Squibb from 2008 to 2010, Manager GCP Auditing at INO Therapeutics/IKARIA, Inc. from 2004 to 2008, and Safety reviewer (contract)/GCP Auditor (contract-permanent) at Glaxo Smith Kline Consumer Health Care from 2003 to 2004. Additionally, they worked as GCP Auditor (contract)/Pharmacovigilance specialist(contract) at Aventis Pasteur from 2001 to 2003. Barbara's expertise and experience make their a valuable asset in the pharmaceutical industry.

Barbara Tantillo RN BSN MS obtained their Master's degree in Regulatory Affairs Quality Assurance from Temple University School of Pharmacy between 2018 and 2022. Prior to that, they completed their Bachelor's degree in Nursing at East Stroudsburg University of Pennsylvania and their Associates degree in Nursing at Middlesex County College. Barbara also studied Six Sigma at Villanova University, although the specific details of their degree are not provided.

Location

Bedminster, United States

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Daiichi Sankyo

21 followers

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.


Industries

Headquarters

Tokyo, Japan

Employees

1,001-5,000

Links